[Federal Register Volume 64, Number 109 (Tuesday, June 8, 1999)]
[Notices]
[Page 30526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Open Meeting for Representatives of Health Professional 
Organizations; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting with representatives of health professional organizations. The 
public meeting will be chaired by Sharon Smith Holston, Deputy 
Commissioner for External Affairs. The two primary topics on the agenda 
for this meeting will be managing risks from medical product use and 
pediatric clinical studies.

DATES: The public meeting will be held on Tuesday, June 15, 1999, from 
1:30 p.m. to 3:30 p.m.

ADDRESSES: The public meeting will be held at the Holiday Inn Bethesda, 
8210 Wisconsin Ave., Bethesda, MD.

FOR FURTHER INFORMATION CONTACT: Peter H. Rheinstein, Office of Health 
Affairs (HFY-40), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6630.
    Those persons interested in attending this meeting should call 
Betty Palsgrove at 301-827-6618 to register. Registration may also be 
transmitted by FAX 1-800-344-3332 or 301-443-2446. Please include the 
name and title of the person attending, the name of the organization, 
address, and telephone number. There is no registration fee, however, 
space is limited. Persons will be registered in the order in which 
calls are received.

SUPPLEMENTARY INFORMATION: The purpose of the public meeting is to 
provide an opportunity for representatives of health professional 
organizations and other interested persons to be briefed by senior FDA 
staff. It will also provide an opportunity for informal discussion on 
these topics of particular interest to health professional 
organizations.
    The scheduled presenters for this meeting will be Janet Woodcock, 
Director, Center for Drug Evaluation and Research (CDER) and M. Diane 
Murphy, Director, Office of Drug Evaluation IV, CDER.

    Dated: June 2, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-14404 Filed 6-7-99; 8:45 am]
BILLING CODE 4160-01-F